ArticleCytotherapy2024

Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation.

David J Graber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.